Results 361 to 370 of about 129,283 (392)
Some of the next articles are maybe not open access.

Methotrexate vs azathioprine in second-line therapy of sarcoidosis.

Chest, 2013
BACKGROUND Steroids remain the first-choice therapeutic in sarcoidosis; however, long-term use is associated with toxicity. Evidence defining the best second-line therapeutic is currently lacking.
A. Vorselaars   +8 more
semanticscholar   +1 more source

Azathioprine and Allopurinol

Annals of Internal Medicine, 1974
Excerpt To the editor: In the recently published review article concerning azathioprine (1) the authors did not mention an important drug interrelationship.
openaire   +2 more sources

Azathioprine

International Journal of Dermatology, 1981
A R, Ahmed, R, Moy
openaire   +2 more sources

Azathioprine

Reactions weekly, 2019

semanticscholar   +1 more source

Treating neuromyelitis optica with azathioprine: 20-year clinical practice

Multiple Sclerosis, 2019
D. Bichuetti   +3 more
semanticscholar   +1 more source

Azathioprine

Clinics in Rheumatic Diseases, 1984
openaire   +2 more sources

Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

Arthritis & Rheumatology, 2017
X. Puéchal   +29 more
semanticscholar   +1 more source

Methotrexate and azathioprine for severe atopic dermatitis: a 5‐year follow‐up study of a randomized controlled trial

British Journal of Dermatology, 2018
L. Gerbens   +5 more
semanticscholar   +1 more source

Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

Clinical Gastroenterology and Hepatology, 2015
D. Kotlyar   +15 more
semanticscholar   +1 more source

Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder

European Journal of Neurology, 2017
Hongxi Chen   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy